Charité – Universitätsmedizin Berlin is one of the largest university hospitals in Europe, where physicians and researchers provide clinical care, research and teaching of the highest international standard. The Charité repre-sents a single medical faculty that serves both the Humboldt-Universität zu Berlin and the Freie Universität Berlin, and is esteemed worldwide for its excellence in teaching and training. The Charité extends over four campuses, and has close to 100 different departments and institutes, which make up a total of 17 different CharitéCenters.
Applications are invited for the following position at the Institute of Pathology in CharitéCenter 5 for Diagnostic Laboratory and Preventive Medicine, to commence as soon as possible:
The professorship is funded by the Joint Federal Government-Länder Funding Programme for Junior Academics (the Tenure-Track Programme). The call for applications is accordingly directed at academics in the first few years after their doctorate. Women are strongly encouraged to apply. The aim is to achieve a proportion of fifty percent women among those awarded tenure-track professorships funded by the program.
The successful candidate is to contribute to the pioneering further development of complex molecular and phenotypic characterizations of tumor diseases for clinical diagnostic use in precision oncology. In doing so, tumor cell hetero-geneity or plasticity are to be taken into account on biologically meaningful and technically ascertainable levels, and complex quantitative biomarkers are to be derived. Core areas of methodological focus can lie, for example, in new analysis techniques, such as single cell, methylation or proteome analyses, or in cellular therapies, preclinical model systems or artificial intelligence. Using such approaches, the successful candidate is to contribute to in-depth char-acterization of tumor diseases, investigate the effects of targeted and experimental therapies, harness such analyses for clinical trials or provide these with diagnostic support.
Given the appropriate qualifications, both natural scientists with a suitable translational focus and doctors with a suitable academic profile can apply for the professorship. The latter should preferably be resident physicians or have completed a residency in pathology.
The professorship is in principle endowed with a tenure track. The junior professorship is initially limited to three years and will be extended for a further three years if the probationary period is judged to be successful. In the penultimate year of the maximum six-year tenure-track phase, following a successful tenure evaluation and given the formal requirements for employment are met, the incumbent will be transferred to a lifetime associate (W2) professorship, in accordance with § 102c of the Berlin Higher Education Act (BerlHG). Procedures, processes and performance criteria are set out in Charité – Universitätsmedizin Berlin’s statute governing tenure-track professorships [www.char-ite.de/en/tenuretrack].
The successful candidate will be responsible for research and teaching in a core area in the field of translational molecular oncology and, if a doctor is appointed, will participate in patient care. The main duties of the future post holder include:
The candidate must be willing to participate actively in interdisciplinary research alliances of the Charité, in particular, for joint activities with the Charité Comprehensive Cancer Center (CCCC), the Berlin Institute of Health (BIH) and the German Consortium for Translational Cancer Research (DKTK).
Applicants should have:
Formal requirements as per § 102a of the Berlin Higher Education Act (BerlHG) are a successfully completed university degree in human medicine, natural or life sciences, or a comparable subject, as well as an outstanding doctorate, a particular talent for academic work and an aptitude for teaching.
The Charité is committed to increasing the proportion of women among its scientific staff; we therefore strongly encourage women to apply. In the event of equally qualified applicants, women will be given preference over men (within the scope of what is permitted by law). Applicants with disabilities will be given preference over equally qualified non-disabled applicants. We value diversity and therefore welcome all applications – regard-less of gender, nationality, social background, religion or age.
The Charité is certified by the “family-friendly university” audit and is a member of the “Dual Career Network Berlin” (www.dualcareer-berlin.de).
Written applications should be submitted together with your conceptual ideas, following the format and require-ments outlined at https://career.charite.de/am/calls/application_notes.pdf, by 11.05.2021 at https://career.charite.de.
Inquiries about the professorship should be directed to Prof. Dr. David Horst (david.horst@charite.de). Formal questions relating to the application process should be addressed to: berufungen@charite.de.